Concepedia

Till A. Röhn

TA

16

Publications

1.1K

Citations

16

H-Index

2001

Active since

Affiliations

Novartis (Switzerland)(Current)

University of Zurich

ETH Zurich

Roche (Switzerland)

Novartis Institutes for BioMedical Research

Till A. Röhn is an author at Novartis (Switzerland) specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

2001–2022

16

Publications

16

Tetraspan microdomains distinct from lipid rafts enrich select peptide–MHC class II complexes

Harald Kropshofer, Sebastian Spindeldreher, Till A. Röhn et al. · Nature Immunology · 2001 · 209 citations

, , +7

Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis

Till A. Röhn, Gary T. Jennings, Marcela Hernández et al. · European Journal of Immunology · 2006 · 193 citations

Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis

Ivo Sonderegger, Till A. Röhn, Michael Kurrer et al. · European Journal of Immunology · 2006 · 162 citations · Full text

, , +18

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

Till A. Röhn, Bettina Wagenknecht, Wilfried Roth et al. · Oncogene · 2001 · 96 citations

, , +8

Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization

Till A. Röhn, Marianne Boes, Dirk Wolters et al. · Nature Immunology · 2004 · 60 citations

, , +7

Rows per page

1–5 of 16